Group 1 - The company has not established a financial shared service center [1] - An investor inquired about the existence and establishment year of a financial shared service center [3] - The investor also asked about the technological tools used in the center and its digitalization score [3]

Group 1 - The core point of the announcement is the resolutions made during the 20th meeting of the 9th Board of Directors of Guizhou Chitianhua Co., Ltd, which includes the approval of expected related party transactions for 2026 and the convening of the first extraordinary shareholders' meeting in 2026 [1][3][4] Group 2 - The board meeting was held on January 14, 2026, with all 9 directors participating, and the procedures complied with relevant laws and regulations [2] - The board approved the proposal regarding expected related party transactions for 2026, which requires further approval from the shareholders' meeting [3][8] - The board also approved the proposal to convene the first extraordinary shareholders' meeting of 2026, with unanimous support from all directors present [4] Group 3 - The expected related party transactions for 2026 are necessary for the smooth operation of the company and adhere to principles of fairness and voluntary participation, ensuring no harm to the interests of the company and its shareholders [7][31] - The company plans to purchase products and services from related parties, including approximately 60.02 million yuan for medical supplies and 4 million yuan for land lease from its controlling shareholder [25][26] - The pricing for these transactions will be based on fair market principles, ensuring that the interests of all shareholders are protected [28][30] Group 4 - The first extraordinary shareholders' meeting is scheduled for January 30, 2026, and will utilize both on-site and online voting methods [34][35] - The meeting will address various proposals, including those requiring the abstention of related shareholders from voting [39]

Group 1 - The company announced the approval of the proposal regarding expected daily related transactions for the year 2026 [2] - The company also approved the proposal to convene the first extraordinary shareholders' meeting of 2026 [2]

Group 1 - The company, Chitianhua, announced that it will hold its first extraordinary general meeting of shareholders for 2026 on January 30, 2026 [2]

因此，我们一致同意预计 2026 年度日常关联交易事项。 独立董事：范其勇、王朴、徐广 贵州赤天化股份有限公司独立董事 关于预计 2026 年度日常关联交易情况的独立意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）、中国 证券监督管理委员会《上市公司独立董事管理办法》、《上市公司治理 准则》、上海证券交易所《股票上市规则》（以下简称"《上市规则》"）、 《上市公司自律监管指引第 1 号——规范运作》及《公司章程》等相 关规定，作为公司的独立董事，我们本着勤勉尽责的态度认真审阅了 公司第九届二十次董事会会议审议的《关于预计 2026 年度日常关联 交易的议案》及相关资料，发表如下意见： 一、本议案提交董事会前已经独立董事专门会议审议通过，独立 董事一致同意将《关于预计 2026 年度日常关联交易的议案》提交公 司董事会审议。公司 2026 年度日常关联交易符合《公司法》、《上市 规则》等相关法律、法规以及《公司章程》的有关规定，本议案已经 公司第九届二十次董事会审议。在董事会会议表决时，公司董事会 9 名成员中 3 名关联董事均回避表决，其余 6 名非关联董事一致同意本 项议案，并同意提交公司股东会 ...

重要内容提示： 是否需要提交股东会审议：是 证券代码：600227 证券简称：赤 天 化 公告编号：2026-004 贵州赤天化股份有限公司 关于预计 2026 年度日常关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2、公司 2026 年度日常关联交易价格是根据公平、公允原则参考 市场价格进行定价，符合公司和全体股东的利益。公司日常关联交易 是必要的，有利于公司生产经营的顺利进行，不存在损害本公司及其 他股东特别是中小股东利益的情况，不会影响公司的独立性。 贵州赤天化股份有限公司（以下简称：公司）预计 2026 年度日 常关联交易事项尚需提交公司股东会审议批准，关联股东将回避表决。 日常关联交易对上市公司的影响 公司 2026 年度日常关联交易，是为了确保公司生产经营顺利进 行，并且遵循了公平、公正、自愿的原则，不存在损害公司和广大股 东利益的情况，不存在对关联方形成依赖的情形，不会对公司本期及 未来的财务状况产生不利影响，也不会影响上市公司的独立性。 一、日常关联交易基本情况 （一）日常关联交易履行的审议程 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 证券代码：600227 证券简称：赤天化 公告编号：2026-005 贵州赤天化股份有限公司 关于召开2026年第一次临时股东会的通知 (一) 股东会类型和届次 2026年第一次临时股东会 召开的日期时间：2026 年 1 月 30 日 14 点 00 分 召开地点：贵阳市观山湖区阳关大道 28 号赤天化大厦 22 楼会议室 (五) 网络投票的系统、起止日期和投票时间。 股东会召开日期：2026年1月30日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 (二) 股东会召集人：董事会 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2026 年 1 月 30 日 至2026 年 1 月 30 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间 ...

贵州赤天化股份有限公司（以下简称：公司）第九届二十次董事 会会议通知和材料于 2026 年 1 月 4 日以书面送达、电子邮件等方式 发出，会议于 2026 年 1 月 14 日以通讯表决的方式召开。会议应参加 表决董事 9 名，实际参加表决董事 9 名，本次会议的召集、召开程序 符合《公司法》等有关法律、行政法规、部门规章、规范性文件和《公 司章程》的有关规定，会议及表决合法有效。 二、董事会会议审议情况 本次董事会会议决议如下： （一）审议通过《关于预计 2026 年度日常关联交易的议案》 证券代码：600227 证券简称：赤 天 化 公告编号：2026-003 贵州赤天化股份有限公司 第九届二十次董事会会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 议案提交董事会审议前已经独立董事专门会议审议通过，独立董 事一致同意将《关于预计 2026 年度日常关联交易的议案》提交公司 董事会审议。独立董事针对本议案相关事项发表了一致同意的独立意 见。 根据《上海证券交易所股票上市规则》等有关规定 ...

Core Viewpoint - The stock of Chitianhua has shown fluctuations with a recent increase of 2.02%, reflecting a total market capitalization of 4.256 billion yuan, while the company faces challenges with declining revenue and net profit [1][2]. Group 1: Stock Performance - As of January 13, Chitianhua's stock price reached 2.52 yuan per share, with a trading volume of 47.56 million yuan and a turnover rate of 1.51% [1]. - Year-to-date, the stock has increased by 5.88%, with a 1.61% rise over the last five trading days, a 7.69% decline over the last 20 days, and a 6.33% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Chitianhua reported a revenue of 1.569 billion yuan, representing a year-on-year decrease of 7.96% [2]. - The company recorded a net profit attributable to shareholders of -152 million yuan, a significant decline of 340.46% compared to the previous year [2]. Group 3: Shareholder Information - As of September 30, the number of shareholders for Chitianhua was 57,600, a decrease of 15.09% from the previous period [2]. - The average number of tradable shares per shareholder increased by 17.77% to 22,191 shares [2]. Group 4: Business Overview - Chitianhua, established on August 28, 1998, and listed on February 21, 2000, is primarily engaged in nitrogen fertilizer and methanol chemical businesses, as well as pharmaceutical distribution and manufacturing [1]. - The revenue composition of the company includes urea (55.06%), methanol (28.10%), compound fertilizer (7.61%), medical services (4.31%), and other segments [1].

Core Viewpoint - Guizhou Chitianhua Co., Ltd. anticipates a net profit attributable to shareholders for the year 2025 to be negative, indicating an expected loss in operating performance for the year [1]. Financial Performance - The company’s financial department has conducted preliminary calculations, leading to the expectation of a loss for the fiscal year 2025 [1]. - The final financial data will be disclosed in the official 2025 annual report, which will adhere to the regulations of the Shanghai Stock Exchange [1]. Disclosure and Compliance - The company commits to following the Shanghai Stock Exchange's listing rules and will expedite the financial accounting process to provide timely updates on the 2025 annual performance forecast [1]. - Designated media for information disclosure includes China Securities Journal, Shanghai Securities Journal, Securities Times, and the Shanghai Stock Exchange website [1].